Other
One Month Blinded Discontinuation Period:
One Month Blinded Discontinuation Period: is an intervention with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Active, not recruiting3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
active_not_recruiting375%
recruiting125%
Recent Activity
4 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)
NCT03457675
active_not_recruitingnot_applicable
Development of Adaptive Deep Brain Stimulation for OCD
NCT04281134
recruitingnot_applicable
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
NCT06599099
active_not_recruitingnot_applicable
Phase II Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder
NCT04806516
Clinical Trials (4)
Showing 4 of 4 trials
NCT03457675Not Applicable
Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)
NCT04281134Not Applicable
Development of Adaptive Deep Brain Stimulation for OCD
NCT06599099Not Applicable
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
NCT04806516Not Applicable
Phase II Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4